Literature DB >> 26586127

Hormetic Potential of Sulforaphane (SFN) in Switching Cells' Fate Towards Survival or Death.

Sanjima Pal, V Badireenath Konkimalla1.   

Abstract

Epidemiological evidences establish sulforaphane (SFN), a hormetic dietary isothiocyanate to be a promising chemopreventive, anti-inflammatory and anti-cancer agent. Beyond a concentration threshold SFN exerts pro-death activities (cell cycle arrest, epigenetic modifications and apoptosis) and below the threshold it either promotes prosurvival autophagy or remains latent. There is a significant lacuna in understanding the underpinning dynamic molecular networks that alternate the pharmacological responses with respect to the intracellular concentration and exposure time that renders SFN to be a characteristic hormetic molecule (display characteristic biphasic dose response curve). Unraveling this multi-targeted SFN triggered molecular interplay between apoptosis and pro-survival autophagy may have great therapeutic implications. From the available literature, here we present a review that illustrates the existence of a hormetic window and briefly discussed its role in the spectrum of activity of SFN in different pathological conditions (cancer and immune-mediated diseases). Further, we hypothesize a hormetic signaling event on how SFN triggers mutually exclusive molecular pathways such as cell survival or death signals depending on its pathophysiological environment, exposure time and in vitro working concentrations. By better understanding these altered events and underpinning mechanisms in different combinations such as concentrations and time a proper therapeutic can be designed.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26586127     DOI: 10.2174/1389557516666151120115027

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  8 in total

1.  Prenylated xanthones from mangosteen (Garcinia mangostana) activate the AhR and Nrf2 pathways and protect intestinal barrier integrity in HT-29 cells.

Authors:  Restituto Tocmo; Bryan Le; Amber Heun; Jan Peter van Pijkeren; Kirk Parkin; Jeremy James Johnson
Journal:  Free Radic Biol Med       Date:  2020-12-09       Impact factor: 7.376

Review 2.  The Role of MicroRNAs in the Chemopreventive Activity of Sulforaphane from Cruciferous Vegetables.

Authors:  Christopher Dacosta; Yongping Bao
Journal:  Nutrients       Date:  2017-08-19       Impact factor: 5.717

Review 3.  Breast Cancer Prevention-Is there a Future for Sulforaphane and Its Analogs?

Authors:  Dominika Kuran; Anna Pogorzelska; Katarzyna Wiktorska
Journal:  Nutrients       Date:  2020-05-27       Impact factor: 5.717

4.  Sulforaphane (SFA) protects neuronal cells from oxygen & glucose deprivation (OGD).

Authors:  Zeenat Ladak; Elizabeth Garcia; Jenny Yoon; Takaaki Landry; Edward A Armstrong; Jerome Y Yager; Sujata Persad
Journal:  PLoS One       Date:  2021-03-18       Impact factor: 3.240

5.  Discovery of Sulforaphane as an Inducer of Ferroptosis in U-937 Leukemia Cells: Expanding Its Anticancer Potential.

Authors:  Giulia Greco; Michael Schnekenburger; Elena Catanzaro; Eleonora Turrini; Fabio Ferrini; Piero Sestili; Marc Diederich; Carmela Fimognari
Journal:  Cancers (Basel)       Date:  2021-12-24       Impact factor: 6.639

6.  Sulforaphane Upregulates Cultured Mouse Astrocytic Aquaporin-4 Expression through p38 MAPK Pathway.

Authors:  Canhong Yang; Sisi Qin; Jiafa Zhang; Yuanyuan Wang; Huan Li; Tianming Lü
Journal:  J Healthc Eng       Date:  2022-08-10       Impact factor: 3.822

7.  Potential of Sulforaphane and Broccoli Membrane Vesicles as Regulators of M1/M2 Human Macrophage Activity.

Authors:  Tamara Ramírez-Pavez; Andrea García-Peñaranda; Paula Garcia-Ibañez; Lucía Yepes-Molina; Micaela Carvajal; Antonio J Ruiz-Alcaraz; Diego A Moreno; Pilar García-Peñarrubia; María Martínez-Esparza
Journal:  Int J Mol Sci       Date:  2022-09-22       Impact factor: 6.208

Review 8.  Biphasic Dose-Response Induced by Phytochemicals: Experimental Evidence.

Authors:  Jadwiga Jodynis-Liebert; Małgorzata Kujawska
Journal:  J Clin Med       Date:  2020-03-06       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.